Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. The new method could be used to take precise three-dimensional images of plaques lining arteries...
A potential vaccine against bacteria that cause serious gastric disorders including stomach cancer may be a step closer following a pioneering study by a University of Guelph chemist. In the first published study of its kind, a team led by Prof. Mario Monteiro, Department of Chemistry, found a...
The plot of my book is a bout a caretaker who goes on a house call and is terrorized by strangers throughout the night. Here is my first chapter :
The Caretaker
Chapter 1- The interview
I nervously tapped the heels of my high shoes on...
A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is co-sponsored by the American...
GenVec, Inc. (Nasdaq: GNVC) announced that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the International Respiratory Syncytial Virus Symposium, which took place in Rotterdam, Netherlands on December 2-5, 2010. The presentation was given by Barney S...
This afternoon, the National Hurricane Prediction Center is using terms like "struggling to maintain its identity," "elongated area of low pressure," "losing definition," "motion is uncertain," "little change in philosophy," "cold," "guidance becomes divergent," "forecast is problematic," "the...
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. Principal investigator Edith Perez, MD, Mayo Clinic...
The American Society of Hematology (ASH) announces the 2010 recipients of its Trainee Research Awards. Through this program, which is designed to encourage the pursuit of research and spark an interest in hematology, 43 medical students, undergraduates, and residents will each receive $4,000 to...
This week, TCA Cellular Therapy's Medical Director Gabriel Lasala, M.D. presents advances in a proprietary combination adult stem cell treatment for acute myocardial infarction at the Society for Cardiovascular Angiography and Interventions (SCAI) scientific conference in San Diego...
Investigators from the International Center for Biomedicine and the University of Chile, in collaboration with the Center for Bioinformatics of the Universidad de Talca, have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET...
Investigators from the International Center for Biomedicine and the University of Chile, in collaboration with the Center for Bioinformatics of the Universidad de Talca, have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET...
Investigators from the International Center for Biomedicine and the University of Chile, in collaboration with the Center for Bioinformatics of the Universidad de Talca, have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET...
Investigators from the International Center for Biomedicine and the University of Chile, in collaboration with the Center for Bioinformatics of the Universidad de Talca, have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET...
Investigators from the International Center for Biomedicine and the University of Chile, in collaboration with the Center for Bioinformatics of the Universidad de Talca, have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET...
Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched breast reconstruction achieved a high rate of patient and physician satisfaction and improvements in overall breast deformity in lumpectomy patients. These results are based on six-month follow up from the...
Quantum computing has long dangled the possibility of superfast, super-efficient processing, and now search giant Google has jumped on board that future.
New Scientist reports that Google has spent the past three years developing a quantum algorithm that can automatically recognize and sort...
Facet Biotech Corporation (NASDAQ: FACT) and Bristol-Myers Squibb Company (NYSE: BMY) announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented at the...
Genta Incorporated (OTCBB: GETA.OB) announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company's lead oncology product, Genasense® (oblimersen sodium) Injection, administered for the first time as a...
As mentioned last week, Toshiba's first batch of 3,000 direct-methanol fuel cell (DMFC) chargers—the first from a major manufacturer—hit Japan on Thursday. The IDG News Service has been testing one, and here are their first impressions:
Some quick background: DMFCs produce electricity from a...